AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-80
Results: 1-25/80
ETIOLOGY AND PATHOGENESIS OF ALZHEIMERS-DISEASE
Authors: FARLOW MR
Citation: Mr. Farlow, ETIOLOGY AND PATHOGENESIS OF ALZHEIMERS-DISEASE, American journal of health-system pharmacy, 55, 1998, pp. 5-10
CEREBROSPINAL-FLUID HOMOVANILLIC-ACID LEVELS IN RAPID-ONSET DYSTONIA-PARKINSONISM
Authors: BRASHEAR A BUTLER IJ HYLAND K FARLOW MR DOBYNS WB
Citation: A. Brashear et al., CEREBROSPINAL-FLUID HOMOVANILLIC-ACID LEVELS IN RAPID-ONSET DYSTONIA-PARKINSONISM, Annals of neurology, 43(4), 1998, pp. 521-526
THE SECRETION OF AMYLOID BETA-PEPTIDES IS INHIBITED IN THE TACRINE-TREATED HUMAN NEUROBLASTOMA-CELLS
Authors: LAHIRI DK FARLOW MR SAMBAMURTI K
Citation: Dk. Lahiri et al., THE SECRETION OF AMYLOID BETA-PEPTIDES IS INHIBITED IN THE TACRINE-TREATED HUMAN NEUROBLASTOMA-CELLS, Molecular brain research, 62(2), 1998, pp. 131-140
PHARMACOLOGICAL TREATMENT OF COGNITION IN ALZHEIMERS DEMENTIA
Authors: FARLOW MR EVANS RM
Citation: Mr. Farlow et Rm. Evans, PHARMACOLOGICAL TREATMENT OF COGNITION IN ALZHEIMERS DEMENTIA, Neurology, 51(1), 1998, pp. 36-44
CLINICAL-FEATURES OF SPHEROID BODY MYOPATHY
Authors: EVANS RM FARLOW MR KOLNER D FOROUD T
Citation: Rm. Evans et al., CLINICAL-FEATURES OF SPHEROID BODY MYOPATHY, Neurology, 50(4), 1998, pp. 1041-1041
METRIFONATE IN THE SYMPTOMATIC TREATMENT OF ALZHEIMERS-DISEASE - INFLUENCE OF APOLIPOPROTEIN-E GENOTYPE
Authors: FARLOW MR LAHIRI DK BRASHEAR A CYRUS PA GULANSKI B
Citation: Mr. Farlow et al., METRIFONATE IN THE SYMPTOMATIC TREATMENT OF ALZHEIMERS-DISEASE - INFLUENCE OF APOLIPOPROTEIN-E GENOTYPE, Neurology, 50(4), 1998, pp. 2010-2010
INFORMANT-RATED CLINICAL DEMENTIA RATING-SCALE - COMPARISON WITH THE CLINICIAN-RATED CLINICAL DEMENTIA RATING-SCALE
Authors: HAKE AM UNVERZAGT FW HENDRIE HC FARLOW MR
Citation: Am. Hake et al., INFORMANT-RATED CLINICAL DEMENTIA RATING-SCALE - COMPARISON WITH THE CLINICIAN-RATED CLINICAL DEMENTIA RATING-SCALE, Neurology, 50(4), 1998, pp. 2019-2019
PREDICTING DRIVING SAFETY IN PATIENTS WITH DEMENTIA
Authors: BRASHEAR A UNVERZAGT FW KUHN ER FARLOW MR HUI S
Citation: A. Brashear et al., PREDICTING DRIVING SAFETY IN PATIENTS WITH DEMENTIA, Neurology, 50(4), 1998, pp. 2022-2022
APO E-EPSILON-4 HOMOZYGOSITY ASSOCIATED WITH AP ANGIOPATHY AND PERIVASCULAR TAU-PATHOLOGY WITHOUT NEURITIC PLAQUES IN SENILE DEMENTIA
Authors: VIDAL RG CALERO M PICCARDO P FARLOW MR UNVERZAGT FW MENDEZ E JIMENEZHUETE A BEAVIS R GALLO B GHISO J FRANGIONE B GHETTI B
Citation: Rg. Vidal et al., APO E-EPSILON-4 HOMOZYGOSITY ASSOCIATED WITH AP ANGIOPATHY AND PERIVASCULAR TAU-PATHOLOGY WITHOUT NEURITIC PLAQUES IN SENILE DEMENTIA, Neurology, 50(4), 1998, pp. 6105-6105
EFFECTS OF TACRINE AND PHYSOSTIGMINE ON THE SECRETION OF SOLUBLE AMYLOID BETA-PEPTIDES
Authors: LAHIRI DK FARLOW MR
Citation: Dk. Lahiri et Mr. Farlow, EFFECTS OF TACRINE AND PHYSOSTIGMINE ON THE SECRETION OF SOLUBLE AMYLOID BETA-PEPTIDES, Neurology, 50(4), 1998, pp. 24005-24005
TREATMENT OUTCOME OF TACRINE THERAPY DEPENDS ON APOLIPOPROTEIN GENOTYPE AND GENDER OF THE SUBJECTS WITH ALZHEIMERS-DISEASE
Authors: FARLOW MR LAHIRI DK POIRIER J DAVIGNON J SCHNEIDER L HUI SL
Citation: Mr. Farlow et al., TREATMENT OUTCOME OF TACRINE THERAPY DEPENDS ON APOLIPOPROTEIN GENOTYPE AND GENDER OF THE SUBJECTS WITH ALZHEIMERS-DISEASE, Neurology, 50(3), 1998, pp. 669-677
A 24-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DONEPEZIL IN PATIENTS WITH ALZHEIMERS-DISEASE
Authors: ROGERS SL FARLOW MR DOODY RS MOHS R FRIEDHOFF LT ALBALA B BAUMEL B BOOKER G DEXTER J FARMER M FEIGHNER JP FERRIS S GORDON B GORMAN DG HANNA G HARRELL LE HUBBARD R KENNEDY J MCCARTHY J SCHARRE DW SCHAERF F SCHNEIDER L SELTZER B SIEGAL A STARK SR STRAUSS A WALSHE TM
Citation: Sl. Rogers et al., A 24-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DONEPEZIL IN PATIENTS WITH ALZHEIMERS-DISEASE, Neurology, 50(1), 1998, pp. 136-145
COGNITIVE DECLINE AND EDUCATION IN MILD DEMENTIA
Authors: UNVERZAGT FW HUI SL FARLOW MR HALL KS HENDRIE HC
Citation: Fw. Unverzagt et al., COGNITIVE DECLINE AND EDUCATION IN MILD DEMENTIA, Neurology, 50(1), 1998, pp. 181-185
MUTATION IN THE TAU-GENE IN FAMILIAL MULTIPLE SYSTEM TAUOPATHY WITH PRESENILE-DEMENTIA
Authors: SPILLANTINI MG MURRELL JR GOEDERT M FARLOW MR KLUG A GHETTI B
Citation: Mg. Spillantini et al., MUTATION IN THE TAU-GENE IN FAMILIAL MULTIPLE SYSTEM TAUOPATHY WITH PRESENILE-DEMENTIA, Proceedings of the National Academy of Sciences of the United Statesof America, 95(13), 1998, pp. 7737-7741
NEW TREATMENTS IN ALZHEIMER-DISEASE AND THE CONTINUED NEED FOR PLACEBO-CONTROLLED TRIALS
Authors: FARLOW MR
Citation: Mr. Farlow, NEW TREATMENTS IN ALZHEIMER-DISEASE AND THE CONTINUED NEED FOR PLACEBO-CONTROLLED TRIALS, Archives of neurology, 55(11), 1998, pp. 1396-1398
FUNCTIONAL BRAIN IMAGING IN APRAXIA
Authors: KAREKEN DA UNVERZAGT F CALDEMEYER K FARLOW MR HUTCHINS GD
Citation: Da. Kareken et al., FUNCTIONAL BRAIN IMAGING IN APRAXIA, Archives of neurology, 55(1), 1998, pp. 107-113
METRIFONATE IMPROVES THE COGNITIVE-ABILITY OF ALZHEIMERS-DISEASE PATIENTS IN A DOSE-RELATED MANNER
Authors: FARLOW MR CYRUS PA GULANSKI B
Citation: Mr. Farlow et al., METRIFONATE IMPROVES THE COGNITIVE-ABILITY OF ALZHEIMERS-DISEASE PATIENTS IN A DOSE-RELATED MANNER, Journal of the American Geriatrics Society, 46(9), 1998, pp. 15-15
OPTIMAL MANAGEMENT OF BEHAVIORAL-DISORDERS ASSOCIATED WITH DEMENTIA
Authors: CLASS CA SCHNEIDER L FARLOW MR
Citation: Ca. Class et al., OPTIMAL MANAGEMENT OF BEHAVIORAL-DISORDERS ASSOCIATED WITH DEMENTIA, Drugs & aging, 10(2), 1997, pp. 95-106
MOLECULAR PATHOLOGY OF CHROMOSOME-17 LINKED MULTIPLE SYSTEM TAUOPATHYWITH PRESENILE-DEMENTIA (MSTD)
Authors: GHETTI B MURRELL J FARLOW MR CROWTHER RA GOEDERT M SPILLANTINI MG
Citation: B. Ghetti et al., MOLECULAR PATHOLOGY OF CHROMOSOME-17 LINKED MULTIPLE SYSTEM TAUOPATHYWITH PRESENILE-DEMENTIA (MSTD), Brain pathology, 7(4), 1997, pp. 1175-1175
CLINICOPATHOLOGICAL CORRELATIONS OF SOLUBLE AMYLOID BETA-PROTEIN PRECURSOR IN CEREBROSPINAL-FLUID IN PATIENTS WITH ALZHEIMER-DISEASE AND CONTROLS
Authors: PESKIND ER LEVERENZ J FARLOW MR ITO RK PROVOW SA SIEGEL RS CLEVELAND M MORGAN CH PANDIAN MR CORBIN S NOCHLIN D SCHELLENBERG GD RASKIND MA WAGNER SL
Citation: Er. Peskind et al., CLINICOPATHOLOGICAL CORRELATIONS OF SOLUBLE AMYLOID BETA-PROTEIN PRECURSOR IN CEREBROSPINAL-FLUID IN PATIENTS WITH ALZHEIMER-DISEASE AND CONTROLS, Alzheimer disease and associated disorders, 11(4), 1997, pp. 201-206
IMPAIRED RECOGNITION OF TRAFFIC SIGNS IN DEMENTED DRIVERS
Authors: BRASHEAR A KUHN ER UNVERZAGT FW GLAZIER BS FARLOW MR
Citation: A. Brashear et al., IMPAIRED RECOGNITION OF TRAFFIC SIGNS IN DEMENTED DRIVERS, Annals of neurology, 42(3), 1997, pp. 35-35
HEREDITARY NEURALGIC AMYOTROPHY - EVIDENCE FOR GENETIC HOMOGENEITY AND MAPPING TO CHROMOSOME 17Q25
Authors: PELLEGRINO JE GEORGE RAV BIEGEL J FARLOW MR GARDNER K CARESS J BROWN MJ REBBECK TR BIRD TD CHANCE PF
Citation: Je. Pellegrino et al., HEREDITARY NEURALGIC AMYOTROPHY - EVIDENCE FOR GENETIC HOMOGENEITY AND MAPPING TO CHROMOSOME 17Q25, Human genetics, 101(3), 1997, pp. 277-283
ALZHEIMERS-DISEASE - CLINICAL IMPLICATIONS OF THE APOLIPOPROTEIN-E GENOTYPE
Authors: FARLOW MR
Citation: Mr. Farlow, ALZHEIMERS-DISEASE - CLINICAL IMPLICATIONS OF THE APOLIPOPROTEIN-E GENOTYPE, Neurology, 48(5), 1997, pp. 30-34
RAPID-ONSET DYSTONIA-PARKINSONISM IN A 2ND FAMILY
Authors: BRASHEAR A DELEON D BRESSMAN SB THYAGARAJAN D FARLOW MR DOBYNS WB
Citation: A. Brashear et al., RAPID-ONSET DYSTONIA-PARKINSONISM IN A 2ND FAMILY, Neurology, 48(4), 1997, pp. 1066-1069
[C-11] CFT PET IN RAPID-ONSET DYSTONIA-PARKINSONISM
Authors: BRASHEAR A MULHOLLAND GK QIHUANG Z FARLOW MR SIEMERS ER DOBYNS WB HUTCHINS G
Citation: A. Brashear et al., [C-11] CFT PET IN RAPID-ONSET DYSTONIA-PARKINSONISM, Neurology, 48(3), 1997, pp. 1116-1116
Risultati: 1-25 | 26-50 | 51-75 | 76-80